(Total Views: 639)
Posted On: 08/08/2020 1:38:53 PM
Post# of 72446
I sense some concern about the swiss drug as we finally have some competition. Just remember that Remdesivir (Gilead) is feeling it more so. They know that their days of being the only game in town are limited and fleeting fast. I think news of the swiss drug starting to circulate actually puts more pressure on Gilead than any press release ever will.
Gilead can either partner up and pay up, or quickly disappear from the COVID-19 market. ***Remember that Gilead started out as, and has focused on antivirals since inception and they have a name brand to protect in that space as well.
As for the Swiss Drug VS. Brilacidin, my money is on Brilacidin all the way. Brilacidin is a BEAST and it’s potential has just started to be unveiled.
Gilead can either partner up and pay up, or quickly disappear from the COVID-19 market. ***Remember that Gilead started out as, and has focused on antivirals since inception and they have a name brand to protect in that space as well.
As for the Swiss Drug VS. Brilacidin, my money is on Brilacidin all the way. Brilacidin is a BEAST and it’s potential has just started to be unveiled.
(7)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
